Quick Answer
HEALTHEQUITY, INC. reported R&D Expense of $262.51 million for fiscal year 2026.
HEALTHEQUITY, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2026 | $262.51M | +9.6% |
| 2025 | $239.51M | +9.5% |
| 2024 | $218.81M | +13.2% |
| 2023 | $193.38M | +22.9% |
| 2022 | $157.36M | +26.1% |
| 2021 | $124.81M | +60.9% |
| 2020 | $77.58M | +121.3% |
| 2019 | $35.06M | +28.0% |
| 2018 | $27.39M | +22.4% |
| 2017 | $22.38M | +32.9% |
| 2016 | $16.83M | +60.3% |
| 2015 | $10.50M | +47.0% |
| 2014 | $7.14M | +68.9% |
| 2013 | $4.23M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | $65.92M | +9.5% | +1.7% |
| July 31, 2025 | $64.80M | +10.6% | +5.5% |
| April 30, 2025 | $61.44M | +9.5% | +2.1% |
| October 31, 2024 | $60.19M | +8.2% | +2.7% |
| July 31, 2024 | $58.58M | +7.0% | +4.4% |
| April 30, 2024 | $56.09M | +5.4% | +0.9% |
| October 31, 2023 | $55.61M | +13.8% | +1.5% |
| July 31, 2023 | $54.77M | +17.6% | +3.0% |
- HEALTHEQUITY, INC. showed an increase of +9.6% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2026 period, HEALTHEQUITY, INC.’s r&d expense has grown by 6107.4% (from $4.23 million to $262.51 million).
- The most recent figure is from HEALTHEQUITY, INC.’s fiscal year 2026 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: